Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of moderate-to-severe chronic graft versus host disease (GvHD). The Phase ...

Orca's cell therapy trounces traditional care in blood cancer phase 3, swimming into space's 'holy grail' By Gabrielle Masson Mar 17, 2025 7:00am ...

Orca Bio targets blood cancer treatment approval next year. expand. Orca Bio co-founder and CEO Ivan Dimov. LiPo Ching | San Francisco Business Times. By Ron Leuty – Senior Reporter, ...

Orca-T is composed of highly purified regulatory T-cells, CD34+ stem cells and conventional T-cells derived from peripheral blood from either related or unrelated matched donors.

Orca-T, an investigational allogeneic T-cell immunotherapy, improved chronic graft-vs-host disease (cGVHD)–free survival compared with allogeneic stem cell transplant (allo-HSCT) in patients ...

An orca pod in the Pacific Ocean off the coast of Mexico has devised a cunning strategy to hunt and kill whale sharks — the world’s largest fish that can grow up to 18 meters (60 feet) in ...

An incredibly rare albino orca was caught on camera leaping out of the ocean, leaving an impassioned wildlife photographer “shaking with excitement.” Japanese freelance photographer Noriyuki ...

LONDON -- Animal rights activists are calling for the release of an orca who has been living in Argentina's largest aquarium for over 30 years. The orca named Kshamenk, pronounced Shamenk, is the ...

An orca who made headlines in 2018 after she carried her dead calf on her head for more than two weeks and a distance of 1,000 miles has given birth again, according to the Center for Whale Research.

Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of moderate-to-severe chronic graft versus host disease (GvHD).